ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 200

Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project

Sen Hee Tay1,2, Bernadette Poh Lee Low3, Pamela Shi Hui Tan2, Zhi Wei Khong2, Siew Hwa Chong4, Amelia Santosa1,2, Anita Yee Nah Lim1,2 and Gim Gee Teng2,5, 1Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Singapore, 3Division of Primary Care, Department of Care Integration and Alliance, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 4Clinical Nursing Unit, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 5Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore, Singapore, Singapore

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: gout

Session Information

Date: Sunday, November 5, 2017

Title: Health Services Research Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

 

Urate-lowering therapy (ULT) is the mainstay of gout treatment.  In our clinics, time to achieve target serum urate (SU) level during ULT titration was 37 weeks, during which 15% of patients developed gout attacks requiring hospitalization and the time from last outpatient visit to incident hospitalization was 16 weeks.  The suboptimal management may be due to infrequent follow-up during ULT.  We implemented and evaluated the efficacy and safety of a novel nurse-led telemedicine intervention for dose escalation (DE) of ULT for gout patients in a real-life clinical practice.

Methods:

Consecutive gout patients fulfilling indications for ULT whose SU ≥ 360 µmol/L were approached.  Patients with estimated GFR < 30 mL/min, cognitive impairment and immobility were excluded.  A bundle of care was designed to support telemedicine as the main intervention led by a nurse.  The bundle components included: nurse education; a safety program (SP) with 6 fortnightly phone calls for adverse drug reactions (ADRs); hotline service and virtual monitoring clinic (VMC) appointments.  The VMC consisted of 6-weekly laboratory investigations at government clinics or hospital, protocolized DE of ULT and courier services for ULT.  Patient satisfaction and adherence were assessed using a questionnaire survey of patient experience and Medication Adherence Report Scale (MARS-5), respectively.  The primary outcome was the time to achieve target SU < 360 µmol/L, variables that trended towards a significant association (p < 0.1) were examined in a multivariable Cox regression model.

Results:

We recruited 100 gout patients from July 2016 to March 2017 with a median age of 52.5 years and 90% men; 53.0% were on pre-existing ULT.  The median time to target SU was 19.0 weeks (IQR 17.5-20.5), with no hospitalizations for gout attacks.  One patient had an ADR, 3 SP phone calls were made to the patient and allopurinol was stopped immediately after the rash developed.  The average Likert summed scores were high and similar to the overall patient satisfaction.  Cox regression model revealed that high levels of education (university versus primary), absence of gout attacks, lower baseline SU and number of VMC appointments in 6 months were associated with attainment of target SU. 

Conclusion:

Our study is the first to describe the utility of telemedicine in gout care.  A nurse-led telemedicine intervention is effective, safe and well-accepted for the management of patients with gout.  Telemedicine has the potential to improve access to care for gout patients, thereby decreasing burden of disability and overall healthcare utilization.

Table 1 .jpg

Table 2.jpg

 


Disclosure: S. H. Tay, None; B. P. L. Low, None; P. S. H. Tan, None; Z. W. Khong, None; S. H. Chong, None; A. Santosa, None; A. Y. N. Lim, None; G. G. Teng, None.

To cite this abstract in AMA style:

Tay SH, Low BPL, Tan PSH, Khong ZW, Chong SH, Santosa A, Lim AYN, Teng GG. Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/implementation-and-evaluation-of-a-novel-nurse-led-telemedicine-intervention-for-dose-escalation-of-urate-lowering-therapy-in-gout-a-clinical-practice-improvement-project/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-and-evaluation-of-a-novel-nurse-led-telemedicine-intervention-for-dose-escalation-of-urate-lowering-therapy-in-gout-a-clinical-practice-improvement-project/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology